PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 5501, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.2731, President's Emergency Plan For AIDS Relief (PEPFAR): intellectual property, access to medicines and public health S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health World Trade Organization intellectual property enforcement issues International market access and intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| MIMI KNEUER | — |
| TOM MOORE | — |
| BYRON PATTERSON | — |
| BILLY TAUZIN | — |
| BRIAN CHRISTOPHER TOOHEY | — |
Copyright/Patent/Trademark CPT
H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent issues H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent issues S.2317, Intellectual Property Enforcement Act of 2007: enforcement S.3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S.3600, Patent Reform Act of 2008: patent reform and related issues International intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| ALAN GILBERT | — |
| JAMES BRYANT HALL | — |
| MIMI KNEUER | — |
| DAVID KORN | — |
| HALLIE AMANDA MARANCHICK | — |
| KENDRA MARTELLO | — |
| BYRON PATTERSON | — |
| HEATHER STRAWN | — |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| BRIAN CHRISTOPHER TOOHEY | — |
| DERRICK WHITE | — |
Health Issues HCR
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1014, Heart Disease Education, Analysis Research, and Treatment for Women Act: reporting and analysis of patient data H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5501, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: public health H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5683, The Government Accountability Office Act: disclosure of data H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: direct-to-consumer drug advertising H.R. 6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008: on-line pharmacy issues H.R. 6378, Strengthening of FDA Integrity Act of 2008: debarment H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6388 The Government Accountability Office Improvement Act of 2008: disclosure of data H.R. 6432, Animal Drug User Fee Amendments of 2008: technical corrections to FDAAA H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: public health S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAYA BERMINGHAM | — |
| RANDY BURKHOLDER | — |
| AMY CHEVALIER EFANTIS | Legislative Director - Rep. Artur Davis |
| ALAN GILBERT | — |
| JAMES BRYANT HALL | — |
| LAURYL DODSON JACKSON | — |
| MIMI KNEUER | — |
| DAVID KORN | — |
| HALLIE AMANDA MARANCHICK | — |
| KENDRA MARTELLO | — |
| TOM MOORE | — |
| BRIAN NAGLE | — |
| BYRON PATTERSON | — |
| LORI REILLY | — |
| RICHARD SMITH | — |
| HEATHER STRAWN | — |
| MATTHEW L SULKALA | Senior Legislative Assistant - Rep. Allen Boyd |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| JENNIFER VAN METER | — |
| DERRICK WHITE | — |
Medicare/Medicaid MMM
H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues H.R. 758, Price Disclosure Regarding Treatment of Breast Cancer: transparency H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007: Medicaid rebate H.R. 2184, Enhanced Health Care Value for All Act of 2007: comparative effectiveness H.R. 3162, Children's Health and Medicare Protection Act of 2007: Medicaid rebate H.R. 4854, False Claims Act Correction Act of 2007: liability issues H.R. 5605, Physician Payments Sunshine Act of 2008: transparency issues H.R. 5683, The Government Accountability Office Act: disclosure of data H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008: comparative effectiveness, federal upper limit for Medicaid pharmacy reimbursement, electronic prescribing, Part D data disclosure, and other issues H.R. 6388 The Government Accountability Office Improvement Act of 2008: disclosure of data H.R. 6684, Medicare Prescription Drug Cost Equalization Act: Part D issues H.R. 6752, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues S. 558, Mental Health Parity Act of 2007: health insurance issues S. 2029, Physician Payments Sunshine Act of 2007: transparency issues S. 2041, False Claims Act Correction Act of 2007: liability issues S.3101, Medicare Improvements for Patients and Providers Act of 2008: comparative effectiveness, federal upper limit for Medicaid pharmacy reimbursement, electronic prescribing, Part D data disclosure, and other issues S. 3118, Preserving Access to Medicare Act of 2008: electronic prescribing, Part D data disclosure, and other issues S. 3396, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3408, Comparative Effectiveness Research Act of 2008: comparative effectiveness
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA MARLENE BERGMAN | — |
| MAYA BERMINGHAM | — |
| RANDY BURKHOLDER | — |
| ANDREA JEAN DOUGLAS | — |
| AMY CHEVALIER EFANTIS | Legislative Director - Rep. Artur Davis |
| ALAN GILBERT | — |
| LAURYL DODSON JACKSON | — |
| ANN KAPLAN | — |
| MIMI KNEUER | — |
| HALLIE AMANDA MARANCHICK | — |
| TOM MOORE | — |
| BYRON PATTERSON | — |
| LORI REILLY | — |
| RICHARD SMITH | — |
| HEATHER STRAWN | — |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| JENNIFER VAN METER | — |
| DERRICK WHITE | — |
| MICHAEL PAUL WOODY | Professional Staff - Senate HELP Committee |
Budget/Appropriations BUD
H.2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009: prescription drug importation H.6947, Department of Homeland Security Appropriations Act, 2009 - Making appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2009, and for other purposes: prescription drug importation S.3181, Department of Homeland Security Appropriations Act, 2009: prescription drug importation S.3182, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2009: Office of the United States Trade Representative (USTR) and related issues S.3230, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009: HHS budget, importation, comparative effectiveness, and Part D benefit issues S.3289, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2009: FDA budget and importation issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAYA BERMINGHAM | — |
| ANDREA JEAN DOUGLAS | — |
| AMY CHEVALIER EFANTIS | Legislative Director - Rep. Artur Davis |
| JAMES BRYANT HALL | — |
| VALERIE HARDIN JEWETT | Legis. Director - Rep. Rodney Frelinghuysen |
| MIMI KNEUER | — |
| KENDRA MARTELLO | — |
| BRIAN NAGLE | — |
| BYRON PATTERSON | — |
| LORI REILLY | — |
| RICHARD SMITH | — |
| MATTHEW L SULKALA | Senior Legislative Assistant - Rep. Allen Boyd |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| DERRICK WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.